Circulating adiponectin concentrations in patients with congestive heart failure.

Heart
J GeorgeA Roth

Abstract

To determine concentrations of adiponectin and its predictive value on outcome in a cohort of patients with congestive heart failure (CHF). Serum and clinical data were obtained for outpatients with clinically controlled CHF (n = 175). Serum concentrations of adiponectin, C reactive protein, N-terminal pro-brain natriuretic peptide (NT-proBNP), interleukin (IL) -1beta, IL-6, IL-8, IL-10, IL-12, tumour necrosis factor alpha and CD-40 ligand were determined. The association of adiponectin with the clinical severity of CHF was sought as well as the predictive value of this adipokine on mortality, CHF hospitalisations or the occurrence of each of these end points. Concentrations of adiponectin were significantly increased in patients with CHF. Patients with higher New York Heart Association class had significantly higher serum concentrations of adiponectin. Adiponectin serum concentrations were lower in patients with diabetes and CHF as well as in patients with ischaemic cardiomyopathy. Serum adiponectin concentration was positively associated with age and NT-proBNP but was negatively correlated with C reactive protein concentrations. Serum adiponectin above the 75th centile was found to be an independent predictor of total mortali...Continue Reading

References

Jul 26, 1990·The New England Journal of Medicine·B LevineM Packer
Mar 27, 1999·Biochemical and Biophysical Research Communications·Y AritaY Matsuzawa
Aug 19, 1999·The New England Journal of Medicine·R W Schrier, W T Abraham
Jun 10, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·K HottaY Matsuzawa
May 10, 2001·The Journal of Clinical Endocrinology and Metabolism·C WeyerP A Tataranni
Jul 13, 2002·Lancet·Robert S LindsayJonathan Krakoff
Nov 27, 2002·Circulation·Yoshihisa OkamotoYuji Matsuzawa
Nov 28, 2002·European Journal of Heart Failure·Peter J PughKevin S Channer
Jan 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Masahiro KumadaUNKNOWN Osaka CAD Study Group. Coronary artery disease
May 30, 2003·European Journal of Endocrinology·Miyao MatsubaraShinji Katayose

❮ Previous
Next ❯

Citations

Oct 3, 2007·Internal and Emergency Medicine·R TarquiniG F Gensini
Mar 23, 2011·Current Heart Failure Reports·An M Van Berendoncks, Viviane M Conraads
Apr 24, 2013·Journal of Cardiovascular Translational Research·Deepa M Gopal, Flora Sam
Jul 25, 2008·Journal of Human Hypertension·E Teijeira-FernandezJ R Gonzalez-Juanatey
Nov 26, 2009·Heart·Flora Sam, Kenneth Walsh
Mar 30, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Karen M O'SheaWilliam C Stanley
Apr 9, 2008·Physiological Reviews·E Dale AbelGary Sweeney
Mar 3, 2012·Circulation Research·William C StanleyKelly A O'Connell
Dec 18, 2013·European Heart Journal. Acute Cardiovascular Care·S J ReinstadlerB Metzler
Dec 20, 2012·Cardiovascular Diabetology·Samuele BaldasseroniFrancesca Tarantini
Jun 26, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Masayuki ShimanoToyoaki Murohara
Mar 26, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Toshinari TanakaMinoru Horie
Apr 16, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Masayuki YamajiMinoru Horie
Mar 6, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Rei ShibataToyoaki Murohara
Nov 27, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Yu-Feng LouKan Dong
Aug 21, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Takahiro OharaMasafumi Kitakaze
Apr 16, 2009·International Heart Journal·Shinya TosaHiroshi Ito
Feb 11, 2010·International Heart Journal·Hiroaki KitaokaYoshinori L Doi
Sep 6, 2008·International Journal of Medical Sciences·Hidekuni Inadera
Feb 1, 2014·Current Treatment Options in Cardiovascular Medicine·Amanda R Vest, James B Young
Nov 1, 2007·Future Cardiology·Rei ShibataToyoaki Murohara
Jan 15, 2014·Best Practice & Research. Clinical Endocrinology & Metabolism·Kieren J Mather, Ronald B Goldberg
Jun 25, 2013·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·T SzabóW Doehner
Sep 14, 2013·Arquivos brasileiros de cardiologia·Gustavo Bernardes de Figueiredo OliveiraLeopoldo Soares Piegas
Aug 16, 2012·Heart Failure Reviews·Min Park, Gary Sweeney
Oct 24, 2012·Heart Failure Reviews·An M Van BerendoncksViviane M Conraads
Dec 1, 2011·Clinical and Experimental Nephrology·Yoshiya HosokawaYuji Matsuzawa
Dec 12, 2012·Critical Reviews in Clinical Laboratory Sciences·Philip W Connelly, G V Ramesh Prasad
Mar 2, 2011·The American Journal of the Medical Sciences·Bingyan GuoMei Wang
May 16, 2009·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Lin-Chau ChangWei-Shiung Yang
Mar 19, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·W H Wilson TangStanley L Hazen
Oct 11, 2011·International Journal of Cardiology·Goran LoncarVera Popovic
Mar 8, 2011·Journal of the Neurological Sciences·Hikaru NagasawaKazuo Minematsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Circulation Journal : Official Journal of the Japanese Circulation Society
Toshihiro TamuraTakeshi Kimura
JAMA : the Journal of the American Medical Association
Tobias PischonEric B Rimm
Arteriosclerosis, Thrombosis, and Vascular Biology
Masahiro KumadaOsaka CAD Study Group. Coronary artery disease
© 2022 Meta ULC. All rights reserved